Human Medicines
This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Added in February 2026
24 February
NEW - 24-25 February CMDh agenda
13…
modified 24/02/2026
Meeting 24-25 February 2026: AgendaMeeting 27-29 January 2026: Agenda
modified 24/02/2026
List of documents published on CMDh website (February 2026)(to be used to locate…
modified 19/02/2026
Chairperson: Priscilla Schoondermark
modified 19/02/2026
Training presentations on Active Substance Master File (ASMF) work sharing…
modified 19/02/2026
Guidance on the work sharing procedure for the assessment of Active Substance…
modified 19/02/2026
An Active Substance Master File (ASMF) can be used to replace the…
modified 19/02/2026
Mandate for the Working Group on Active Substance Master File…
modified 19/02/2026
Meeting with Interested Parties - 19 November 2025
MinutesPresentationsCMDh -…
modified 16/02/2026
Pneumovax and associated names (pneumococcal polysaccharide…
modified 13/02/2026